Serum levels of tumour necrosis factor-α predict response to recombinant human erythropoietin in patients with myelodysplastic syndrome
Data up to Jan 2025
Total Citations Per Year
Abstract
References (26)
Reporting results of cancer treatment
1981 • 7,916 citations
Proposals for the classification of the myelodysplastic syndromes
1982 • 3,616 citations
Decreased Erythropoietin Response in Patients with the Anemia of Cancer
1990 • 680 citations
Progress in understanding the pathogenesis of the anemia of chronic disease [see comments]
1992 • 612 citations
Effect of inflammatory cytokines on hypoxia-induced erythropoietin production
1992 • 518 citations
Progress in understanding the pathogenesis of the anemia of chronic disease [see comments]
1992 • 475 citations
Efficacy of erythropoietin in the myelodysplastic syndromes: a meta‐analysis of 205 patients from 17 studies
1995 • 359 citations
Erythropoietin
1991 • 321 citations
Measurement of serum cytokine levels in patients with myelodysplastic syndromes.
1992 • 150 citations
Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes [see comments]
1991 • 144 citations
Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes [see comments]
1991 • 117 citations
The use of r‐HuEpo in the treatment of anaemia related to myelodysplasia (MDS)
1995 • 114 citations
Circulating erythropoietin in patients with myelodysplastic syndromes
1989 • 94 citations
Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia
1990 • 94 citations
Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia
1991 • 66 citations
Prediction of response to treatment with human recombinant erythropoietin in myelodysplastic syndromes.
1993 • 57 citations
Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: A clinical and erythrokinetic assessment
1992 • 52 citations
Clinical implications of cytokine and soluble receptor measurements in patients with newly‐diagnosed aggressive non‐Hodgkin's lymphoma
1995 • 49 citations
Erythropoietin treatment in patients with myelodysplastic syndrome and anemia.
1991 • 47 citations
Serum erythropoietin concentrations in patients with myelodysplastic syndromes
1991 • 29 citations
Increased levels of soluble interleukin-2 receptors and tumor necrosis factor in serum of patients with myelodysplastic syndromes [letter] [see comments]
1991 • 28 citations
Subcutaneous Recombinant Human Erythropoietin for the Treatment of Anemia in Myelodysplastic Syndromes
1993 • 24 citations
Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes
1994 • 23 citations
Efficacy of Recombinant Human Erythropoietin in the Treatment of Refractory Anemias Without Excess of Blasts in Myelodysplastic Syndromes
1994 • 19 citations
Myelodysplastic syndrome
1995 • 14 citations
Serum erythropoietin level and marrow erythroid infiltration predict response to recombinant human erythropoietin in myelodysplastic syndromes.
1993 • 11 citations